PO.BCS01.13 · 生物信息与计算

来自Xenium RNA和蛋白质的无量纲、零校准空间指数用于乳腺IDC和肺腺癌

Dimensionless, null-calibrated spatial indices from Xenium RNA and protein in breast IDC and lung adenocarcinoma

海报缩略图:来自Xenium RNA和蛋白质的无量纲、零校准空间指数用于乳腺IDC和肺腺癌
编号 6909 展板 22 时间 4/22 09:00–12:00 区域 Section 4 主讲 Jinghao Tian Tian, BS
分会场 New Algorithms and Computational Methods
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Jinghao Tian1, Tommy Tran2, Elim Cheung2, Rikita Gakhar2, Vidyodhaya Sundaram2

1Johns Hopkins University, Baltimore, MD,2BioChain Institute, Inc., Newark, CA

摘要 Abstract

中文摘要
肿瘤-免疫微环境的空间特征,包括肿瘤边界处的免疫排斥、三级淋巴结构和检查点结合,塑造了局部控制和治疗反应,然而常规的单标记IHC或批量检测会遗漏单细胞背景和细胞间相互作用。同切片空间多组学现可测量相互作用细胞中的转录组(RNA)和蛋白质组(蛋白质)。从这些数据设计出紧凑的度量指标以比较区域和病例。对来自FFPE组织的两张Xenium切片进行了分析,每张切片均包含来自乳腺浸润性导管癌和肺腺癌的配对原发肿瘤(PT)和邻近正常(PN)区域,使用人类免疫肿瘤学面板加上六个蛋白质子面板。感兴趣区域(ROIs)为分析单元。细胞类型采用SingleR针对公共单细胞参考进行注释,并检查了空间形态。分割显示出预期的差异:PT乳腺以腔上皮为主,伴有基质和免疫异质性,而PN乳腺富含成纤维细胞。肺样本包含上皮、成纤维细胞、内皮和免疫细胞群,在PT和PN之间存在变化,为计算空间指数提供了多样的微环境。三个无量纲指数量化了肿瘤-免疫微环境的互补特征。排斥指数(EI)整合了CD8 T细胞对肿瘤巢的浸润减少、瘤周巨噬细胞富集以及抗原提呈细胞进入减少。TLS评分识别与三级淋巴结构一致的B/T聚集,并由局部趋化因子信号和简单的成熟度替代指标支持。检查点接触指数(CCI)量化PD-1阳性T细胞与PD-L1阳性肿瘤或髓系邻近细胞在小半径内的邻接程度,并与ROI标签打乱的空间零模型进行比较。对于所有指数,数值在每个病例内以PN区域为中心,在肿瘤类型内转换为z评分,并缩放至0-1。该流程产生了连贯的细胞分型和指数汇总,与可见的组织学和肿瘤-正常异质性一致,为描述性解读提供了定量补充。将这些指数建立在同切片RNA和蛋白质以及明确的空间零模型基础上,产生了一个实用框架,用于在小样本量切片上报告肿瘤-免疫微环境,并提供一种可在研究和病理团队间转移的通用语言。
查看英文原文 English abstract
Spatial features of the tumor-immune microenvironment, including immune exclusion at tumor borders, tertiary lymphoid structures, and checkpoint engagement, shape local control and treatment response, yet routine single-marker IHC or bulk assays miss single-cell context and cell-cell interactions. Same-section spatial multi-omics now measure transcriptome (RNA) and proteome (protein) in interacting cells. Compact metrics are designed from these data to compare regions and cases. Two Xenium slides from FFPE tissue were profiled, each including paired primary tumor (PT) and adjacent normal (PN) regions from breast invasive ductal carcinoma and lung adenocarcinoma using a Human Immuno-Oncology panel plus six protein subpanels. Regions of interest (ROIs) were the analysis unit. Cell types were annotated with SingleR against public single-cell references, and spatial morphologies were inspected. Segmentations showed expected differences: PT breast was dominated by luminal epithelium with stromal and immune heterogeneity, whereas PN breast was fibroblast rich. Lung samples contained epithelial, fibroblast, endothelial, and immune populations with shifts between PT and PN, providing diverse microenvironments on which spatial indices were computed. Three dimensionless indices quantified complementary features of the tumor-immune microenvironment. The Exclusion Index (EI) integrates reduced CD8 T-cell penetration into tumor nests with peritumoral macrophage enrichment and diminished antigen-presenting-cell ingress. The TLS Score identifies B/T aggregates consistent with tertiary lymphoid structures, supported by local chemokine signal and simple maturity surrogates. The Checkpoint Contact Index (CCI) quantifies adjacency between PD-1-positive T cells and PD-L1-positive tumor or myeloid neighbors within a small radius compared with ROI label-shuffle spatial nulls. For all indices, values were centered on PN regions within each case, converted to z-scores within tumor type, and scaled 0-1. The pipeline produced coherent cell-typing and index summaries that aligned with visible histology and tumor-normal heterogeneity, providing a quantitative complement to descriptive reads. Grounding the indices in same-section RNA and protein and explicit spatial nulls yields a practical framework for reporting tumor-immune microenvironment on small-N slides and a common language transferable across studies and pathology teams.
利益披露 Disclosure
J. Tian, None. T. Tran, BioChain Institute, Inc. Employment. E. Cheung, BioChain Institute, Inc. Employment. R. Gakhar, BioChain Institute, Inc. Employment. V. Sundaram, BioChain Institute, Inc. Employment.

← 返回 AACR 2026 检索